Explaining detection results and referrals to the patient clinical trials

PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.

This study looks at a new care plan called PASCA for people with multiple myeloma, aged 18-70, after a stem cell transplant. It aims to see if this plan helps prevent or manage problems often linked with the condition or its treatments.